Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Isu Abxis Co. Ltd.
DescriptionBiosimilar of fabrazyme
Molecular Target
Mechanism of ActionEnzyme replacement therapy; Biosimilar
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase II
Standard IndicationFabry's disease
Indication DetailsTreat Fabry's disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today